Anika Therapeutics, Inc. (NASDAQ:ANIK)

CAPS Rating: 5 out of 5

The Company develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.

Recs

0
Player Avatar TerryHoodSr (< 20) Submitted: 9/15/2012 11:40:47 PM : Outperform Start Price: $14.28 ANIK Score: -1.22

2013 EPS $.91 TP $17.2

Report this Post Reply

Featured Broker Partners


Advertisement